Healthcare -
Biotechnology - NASDAQ - US
$ 5.4
9.09 %
$ 46.3 M
Market Cap
-0.39
P/E
KPTI - STOCK-BASED COMPENSATION
Stock-based Compensation KPTI - Karyopharm Therapeutics Inc.
18.4 M
LAST VALUE
-27.85%
2 YEAR CAGR
3.80%
5 YEAR CAGR
2.61%
10 YEAR CAGR